View Older Stories View More Recent Stories

Jul 26, 2023 06:45AM Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma
Jun 5, 2023 08:01AM Moderna (MRNA) and Merck (MRK) Announce mRNA-4157 in Combination With KEYTRUDA Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Pat
May 25, 2023 12:00PM Financial Literacy for All Welcomes American Express, Dow Jones, and Moderna to its Mission of Advancing Financial Literacy
May 16, 2023 06:00AM Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Apr 10, 2023 05:48AM Moderna (MRNA) and Merck (MRK) Report MRNA-4157/V940 in Combination With Keytruda Received Prime Scheme Designation in EU
Mar 30, 2023 05:00AM Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution
Feb 22, 2023 07:04AM Moderna (MRNA) And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
Feb 22, 2023 07:00AM Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
Feb 3, 2023 08:46AM Personalis (PSNL), Moderna (MRNA) Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
Feb 3, 2023 08:45AM Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
Jan 5, 2023 04:06PM Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Jan 5, 2023 04:05PM CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Jan 5, 2023 04:05PM Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Dec 19, 2022 08:19AM Tesla, Moderna, Mesa Air rise premarket; Meta Platforms lower
Aug 16, 2022 07:00AM Senda Biosciences Announces Close of $123 Million Series C Financing
May 24, 2022 08:30AM Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
Apr 28, 2022 07:23AM Moderna files for U.S. authorization of COVID shot for kids under 6
Mar 17, 2022 07:31AM Alnylam Pharma (ALNY) Files Patent Infringement Suits against Pfizer (PFE) and Moderna (MRNA)
Feb 15, 2022 10:05AM INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
Jan 26, 2022 09:31AM Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology
Dec 20, 2021 07:05AM Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies
Dec 17, 2021 02:22PM 'Tidal wave': Omicron could put U.S. COVID-19 surge into overdrive
Nov 29, 2021 09:30AM Pre-Open Stock Movers 11/29: (KRYS) (ADGI) (TWTR) Higher; (MRK) (UPS) Lower (more...)
Oct 22, 2021 09:20AM Pre-Open Stock Movers 10/22: (PHUN) (DWAC) (MAT) Higher; (MTCR) (SNAP) (INTC) Lower (more...)
Oct 13, 2021 10:11AM Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change
Oct 13, 2021 12:35AM Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios
Aug 30, 2021 06:30AM Laronde Attracts $440M in First External Financing to Further Advance Endless RNA™ Platform
Aug 12, 2021 11:27PM U.S. authorizes third shot of COVID-19 vaccines for the immunocompromised
Jul 15, 2021 10:00AM Qatar re-opens for fully vaccinated international travellers
Mar 8, 2021 09:01AM Baxter BioPharma Solutions (BAX) and Moderna (MRNA) Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
Mar 8, 2021 09:00AM Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
Nov 30, 2020 05:22PM FDA Advisory Committee to Meet Dec. 17 on Moderna (MRNA) EAU for its COVID-19 Vaccine
Nov 16, 2020 11:21AM Exclusive: EU eyes COVID vaccine deal with Moderna at less than $25 per dose, says source
Oct 6, 2020 12:56PM U.S. FDA safety guidelines likely to push COVID-19 vaccine authorization past election
Sep 8, 2020 06:31AM Vaccine makers announce pledge, outlining united commitment to uphold integrity of scientific process
Sep 8, 2020 06:31AM Biopharma Leaders Unite to Stand With Science
Sep 8, 2020 06:30AM Biopharma Leaders Unite to Stand with Science
Sep 8, 2020 06:30AM Biopharma Leaders Unite To Stand With Science
Sep 8, 2020 06:30AM Biopharma Leaders Unite to Stand with Science
Sep 8, 2020 06:30AM Biopharma Leaders Unite to Stand with Science
Aug 3, 2020 09:00AM Indigo Ag Announces an Additional $360M in Financing, Appoints Stéphane Bancel, Moderna CEO, to Board of Directors
Jul 13, 2020 10:35AM Moderna, Inc. (MRNA) to Join the NASDAQ-100 Index Beginning July 20
Jul 13, 2020 10:33AM Moderna, Inc. to Join the NASDAQ-100 Index Beginning July 20, 2020
May 27, 2020 12:40PM Moderna (MRNA) coronavirus vaccine tester fainted, had high fever during trial - NY Post
May 19, 2020 12:26PM Vaccine not only for rich, Cuomo says, and decries leadership by tweet
May 1, 2020 06:13AM Moderna (MRNA) and Lonza Announce Worldwide Pact to Manufacture Moderna’s Vaccine Against Novel Coronavirus
May 1, 2020 12:50AM Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
Mar 17, 2020 12:31PM German coronavirus vaccine developer CureVac denies any U.S. bid
Oct 24, 2019 02:21PM Moderna Named Top Employer by Science for Fifth Consecutive Year
Jun 3, 2019 05:40AM Moderna (MRNA) Reports Interim Data from Phase 1 Study of mRNA Personalized Cancer Vaccine at ASCO 2019 Meetings
View More Recent Stories View Older Stories